Research Areas
In this section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
1909 | A 1070722 | Selective inhibitor of GSK-3 | €95.00 | |
1698 | A 770041 | Orally active src-family selective lck inhibitor | €140.00 | |
2971 | Amcasertib | First-in-class stemness kinase inhibitor | €145.00 | |
1857 | AP 24534 | BCR-ABL kinase inhibitor (including T315I mutation) | €70.00 | |
2167 | AR-A 014418 | ATP-competitive GSK-3 inhibitor | €85.00 | |
3041 | ARN 3236 | Potent, selective, ATP-competitive, and orally available inhibitor of SIK2 | €80.00 | |
2187 | AS 1892802 | Potent, selective, ATP-competitive ROCK inhibitor | €95.00 | |
2005 | ASP 3026 | Inhibitor of the oncogenic fusion kinase EML4-ALK | €80.00 | |
2166 | AT 13148 dihydrochloride | ATP-competitive inhibitor of multi-AGC kinases | €70.00 | |
5051 | Axon Ligands™ Cell signaling and Oncology compound library | Axon Ligands™ Cell signaling and Oncology compound library | Inquire | |
5053 | Axon Ligands™ Stem cell compound library | Axon Ligands™ Stem cell compound library | Inquire | |
2669 | AZ13705339 | Potent and selective PAK1 inhibitor | €125.00 | |
2171 | AZD1080 | Selective inhibitor of GSK-3α and GSK-3β | €90.00 | |
2795 | AZD1208 | Pim kinase inhibitor | €70.00 | |
2194 | AZD2858 hydrochloride | Potent and highly selective Glycogen Synthase Kinase-3β inhibitor | €95.00 | |
2981 | B106 | Potent and selective PKC-δ inhibitor | €135.00 | |
3832 | BAY-1816032 | Potent and selective BUB1 (Mitotic checkpoint serine/threonine-protein kinase) inhibitor | Inquire | |
1544 | BIBW 2992 | EGFR and ErbB-2/HER2 tyrosine kinase inhibitor | €50.00 | |
1693 | BIO | GSK-3 inhibitor | €90.00 | |
2798 | BPKDi | PKD inhibitor | €155.00 | |
2931 | BRD0705 | First-in-class, paralog selective GSK3α inhibitor | €210.00 | |
3153 | BRD5648 | Negative control compound of BRD0705 as a GSK3α inhibitor | €180.00 | |
2753 | CCG 232601 | Rho/MRTF/SRF transcriptional pathway inhibitor | €160.00 | |
3092 | CCG-203971 | Rho/MRTF/SRF transcriptional pathway inhibitor | €60.00 | |
3069 | CCG-222740 | Potent and selective Rho/MRTF/SRF transcriptional pathway inhibitor | €145.00 | |
1126 | CHIR98014 | GSK-3 inhibitor | €99.00 | |
1386 | CHIR99021 | GSK-3 inhibitor | €60.00 | |
2435 | CHIR99021 dihydrochloride | GSK-3 inhibitor | €60.00 | |
1976 | CID 2011756 | ATP-competitive and cell-permeable PKD inhibitor | €125.00 | |
1627 | CID 755673 | PKD inhibitor | €125.00 |